Berlin - Delayed Quote EUR
SynBiotic SE (SBX.BE)
3.1050
-0.0500
(-1.58%)
At close: May 16 at 8:01:55 AM GMT+2
Loading Chart for SBX.BE
- Previous Close
3.1550 - Open
3.1050 - Bid 3.0750 x --
- Ask 3.2800 x --
- Day's Range
3.1050 - 3.1050 - 52 Week Range
2.7200 - 9.9600 - Volume
0 - Avg. Volume
4 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: SBX.BE
View MorePerformance Overview: SBX.BE
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
SBX.BE
29.43%
DAX P (^GDAXI)
19.38%
1-Year Return
SBX.BE
68.51%
DAX P (^GDAXI)
26.84%
3-Year Return
SBX.BE
82.72%
DAX P (^GDAXI)
70.20%
5-Year Return
SBX.BE
88.70%
DAX P (^GDAXI)
127.11%
Compare To: SBX.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.0200
0.00%
Mkt Cap AUD 7.577M
Industry Drug Manufacturers—Specialty & Generic
412.50
-0.10%
Mkt Cap ILA 56.888M
Industry Drug Manufacturers—Specialty & Generic
0.5500
-1.79%
Mkt Cap GBp 13.137M
Industry Drug Manufacturers—Specialty & Generic
0.0200
0.00%
Mkt Cap CAD 520,478
Industry Drug Manufacturers—Specialty & Generic
1.8500
-0.54%
Mkt Cap AUD 102.123M
Industry Drug Manufacturers—Specialty & Generic
0.3778
0.00%
Mkt Cap 43.218M
Industry Drug Manufacturers—Specialty & Generic
Statistics: SBX.BE
View MoreValuation Measures
As of 5/16/2025
Market Cap
17.39M
Enterprise Value
18.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.82
Price/Book (mrq)
1.10
Enterprise Value/Revenue
4.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--